Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Kurosh Parsi"'
Autor:
Mandy Wong, Kurosh Parsi, Kenneth Myers, Marianne De Maeseneer, Joseph Caprini, Attilio Cavezzi, David E Connor, Alun H Davies, Sergio Gianesini, Jean-Luc Gillet, Louis Grondin, Jean-Jérôme Guex, Claudine Hamel-Desnos, Nick Morrison, Giovanni Mosti, Alvaro Orrego, Hugo Partsch, Eberhard Rabe, Pauline Raymond-Martimbeau, Michel Schadeck, Roberto Simkin, Lorenzo Tessari, Paul K Thibault, Jorge H Ulloa, Mark Whiteley, Takashi Yamaki, Steven Zimmet, Mina Kang, Selene Vuong, Anes Yang, Lois Zhang
Publikováno v:
Phlebology: The Journal of Venous Disease. 38:205-258
Background Sclerotherapy is a non-invasive procedure commonly used to treat superficial venous disease, vascular malformations and other ectatic vascular lesions. While extremely rare, sclerotherapy may be complicated by serious adverse events. Objec
Publikováno v:
Australasian Journal of Dermatology. 64:255-259
Autor:
Kurosh Parsi, Mina Kang
Publikováno v:
Australasian Journal of Dermatology. 63:235-239
Facial capillary malformations (CMs) become hypertrophic and nodular overtime and pose great therapeutic challenge. Here, we describe safe and effective use of tumescent-assisted sclerotherapy (TAS) in conjunction with yellow vascular laser (577 nm)
Autor:
Kurosh Parsi, Peter Subramaniam, Alun H. Davies, Antonios Gasparis, Peter Gloviczki, William A Marston, Mark Meissner, Christopher Rogan, Andre van Rij
Publikováno v:
Phlebology.
International evidence-based guidelines recommend preoperative duplex ultrasound mapping in the assessment of chronic venous disease, and concurrent ultrasound imaging to guide superficial endovenous interventions such as endovenous laser ablation, r
Publikováno v:
Phlebology. 37(9)
Tissue necrosis is a serious but rare complication of sclerotherapy. Early detection and targeted management are essential to prevent progression and minimise serious complications. In the first instalment of this paper, we reviewed the pathogenic me
Publikováno v:
Phlebology: The Journal of Venous Disease. :026835552311750
Publikováno v:
Phlebology: The Journal of Venous Disease. 36:771-778
Objectives Contrast agents are used widely in the interventional setting and in particularly in the management of vascular anomalies and have also been used in combination with sclero-embolic agents. There is limited information on the interaction of
Autor:
David Connor, Kurosh Parsi
Publikováno v:
Phlebology: The Journal of Venous Disease. 38:196-197
Autor:
Kurosh Parsi, Peter Subramaniam, Alun H. Davies, Antonios Gasparis, Peter Gloviczki, William A. Marston, Mark Meissner, Christopher Rogan, Andre van Rij
Publikováno v:
Journal of vascular surgery. Venous and lymphatic disorders. 10(6)
International evidence-based guidelines recommend preoperative duplex ultrasound mapping in the assessment of chronic venous disease, and concurrent ultrasound imaging to guide superficial endovenous interventions such as endovenous laser ablation, r
Publikováno v:
Phlebology. 37(6)
Background: Tissue necrosis is a significant but uncommon complication of sclerotherapy. The pathogenic mechanisms of this often-debilitating complication have been poorly described in the literature. Purpose: To elucidate the pathological mechanisms